paclitaxel has been researched along with Ache in 88 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.14) | 18.7374 |
1990's | 13 (14.77) | 18.2507 |
2000's | 28 (31.82) | 29.6817 |
2010's | 35 (39.77) | 24.3611 |
2020's | 11 (12.50) | 2.80 |
Authors | Studies |
---|---|
Adamek, P; Bhattacharyya, A; Heles, M; Palecek, J; Pontearso, M; Slepicka, J | 1 |
Feng, S; Mao, M; Wang, J; Wang, X; Zhang, S; Zhou, F | 1 |
Arribas, I; Di Lernia, D; Díaz-Beveridge, R; Gutierrez, A; Hindi, N; Ledesma, P; Lopez-Martin, JA; Lopez-Pousa, A; Luna, P; Marcilla, D; Martin-Broto, J; Martinez-Marin, V; Martinez-Trufero, J; Morales, JM; Moura, DS; Redondo, A; Valverde, C; Zamora, J | 1 |
Cao, P; Wang, G; Wang, N; Xu, J; Ye, X | 1 |
Ardisson-Araújo, DMP; Becker, G; Brusco, I; de Andrade, CM; Machado-De-Avila, RA; Oliveira, MS; Oliveira, SM; Palma, TV; Pillat, MM; Sampaio, TB; Scussel, R; Steiner, BT | 1 |
Ahmad, A; Boitano, S; DeFea, KA; Dussor, G; Kume, M; Price, TJ; Vagner, J | 1 |
Iida, Y; Odajima, S; Okamoto, A; Saito, M; Tabata, J; Ueda, K; Yamada, K; Yanaihara, N; Yokomizo, R | 1 |
Farquhar-Smith, P; Gordon-Williams, R | 1 |
Brusco, I; Ferreira, J; Hausen, BDS; Moresco, RN; Oliveira, SM; Pinheiro, KV; Rigo, FK | 1 |
Cheung, CW; Gu, P; Iadarola, M; Saligan, L; Ti, LK; Wang, XM; Wong, SSC | 1 |
Damaj, MI; Fowlkes, AN; Kurtz, MC; Lichtman, AH; Mann, J; May, MM; Meade, JA; Mustafa, M; Toma, WB; Warncke, UO; Wood, MJ | 1 |
Duggett, NA; Flatters, SJL; Griffiths, LA | 1 |
Bigbee, JW; Legakis, LP; Negus, SS | 1 |
Barzilay, R; Enzinger, A; Forsyth, AW; Hughes, KS; Lindvall, C; Lorenz, KA; Lui, D; Tulsky, JA | 1 |
Alù, M; Blasi, L; Cicero, G; De Luca, R; Gristina, V | 1 |
Abrams, G; Chesney, M; Conley, YP; Hammer, M; Kober, KM; Levine, JD; Mastick, J; Mazor, M; Miaskowski, C; Olshen, A; Paul, SM; Schumacher, M; Smoot, B | 1 |
Boujedaini, N; Mensah-Nyagan, AG; Meyer, L; Patte-Mensah, C; Vitet, L | 1 |
Albadri, S; Alberio, L; Barsotti, N; Beltrame, M; Bercier, V; Boender, AJ; Colecraft, HM; Contestabile, A; Del Bene, F; Di Luca, M; Ji, Y; Khanna, R; Kukovetz, K; Locarno, A; Luo, S; Marcello, E; Moleri, S; Moroni, A; Moutal, A; Pasqualetti, M; Pelucchi, S; Porro, A; Romani, G; Romano, E; Saponaro, A; Simeoni, F; Thiel, G; Tonini, R | 1 |
Ali, MW; Gao, M; Hooks, SB; Li, F; Maixner, DW; Weng, HR; Yadav, R; Yan, X | 1 |
Dantzer, R; Edralin, JD; Heijnen, CJ; Kavelaars, A; Laumet, G | 1 |
DeRubeis, MB; Foster, JC; Mason, H; Taylor, JM; Worden, FP | 1 |
Castro Junior, CJ; Cordeiro, Mdo N; Dalmolin, GD; Ferreira, J; Gomez, MV; Klafke, JZ; Montijo, D; Rigo, FK; Rossato, MF; Silva, MA; Tonello, R; Trevisan, G | 1 |
Mensah-Nyagan, AG; Meyer, L; Patte-Mensah, C; Taleb, O | 1 |
Mazzocato, C | 1 |
Cui, Y; Huang, ZZ; Li, D; Li, YY; Liu, CC; Xin, WJ; Zhang, WW; Zhu, HQ | 1 |
Bottomley, A; Coens, C; Ediebah, DE; Flechtner, H; Gotay, C; Greimel, E; King, MT; Quinten, C; Reeve, BB; Ringash, J; Schmucker von Koch, J; Smit, EF; Taphoorn, MJ; Weis, J; Zikos, E | 1 |
Kozachik, SL; Opp, MR; Page, GG | 1 |
He, Y; Wang, ZJ | 1 |
Ishiyama, T; Jinguu, A; Kikuchi, J; Matsumoto, H; Suzuki, T | 1 |
Gui, Q; Li, D; Xia, S; Xu, C; Yu, S; Zhuang, L | 1 |
Flatters, SJ; Griffiths, LA | 1 |
Blaker, AL; Mitchell, CM; Semple, EA | 1 |
Chen, H; Li, D; Luo, XH; Sun, Y; Xia, W; Xiong, YC | 1 |
Bowman, L; John, W; Liepa, AM; Melemed, A; Peterson, P; Shen, W; Smyth, EN | 1 |
de Santis, V; Duggett, NA; Flatters, SJ; Griffiths, LA; McKenna, OE; Mokori, EB; Yongsanguanchai, N | 1 |
Ishikura, H; Kamitani, N; Kawabata, A; Kawaishi, Y; Liu, K; Nishibori, M; Nishida, T; Sekiguchi, F; Tsubota, M; Yamanishi, H | 1 |
Espirito, JL; Pusztai, L; Valero, V; Wilson, NM | 1 |
Andoh, T; Gauchan, P; Kato, A; Kuraishi, Y; Sasaki, A | 1 |
Andoh, T; Fujita, M; Gauchan, P; Ikeda, K; Kato, A; Kuraishi, Y; Sasaki, A | 1 |
Bae, WK; Cho, SH; Chung, IJ; Hwang, JE; Lee, SJ; Shim, HJ; Yoon, JY | 1 |
Bedikian, AY; Homsi, J; Hwu, P; Hwu, WJ; Kim, KB; Mahoney, SL; Papadopoulos, NE | 1 |
Abdi, S; Gwak, YS; Kim, HK; Zhang, YP | 1 |
Astruc-Diaz, F; Craig, S; Diaz, P; Munoz, E; Naguib, M; Xu, JJ | 1 |
Kawamata, T; Kiya, T; Namiki, A; Yamakage, M | 1 |
Burger, KN; Dakhil, SR; Jaslowski, AJ; Kamal, A; Lachance, DH; Le-Lindqwister, NA; Loprinzi, CL; Novotny, PJ; Reeves, BN; Sloan, JA; Soori, GS; Wolf, SL | 1 |
Chen, X; Green, PG; Levine, JD | 1 |
Chen, C; Lu, Y; Wang, L; Xu, F; Xu, S; Zhang, H; Zhou, X | 1 |
Egashira, N; Kawashiri, T; Masuguchi, K; Oishi, R; Ushio, S; Yamashita, Y | 1 |
Kanetake, H; Matsuo, T; Miyata, Y; Nomata, K; Ohba, K; Sagara, Y; Sakai, H | 1 |
Boyette-Davis, JA; Bruel, BM; Cata, JP; Dougherty, PM; Driver, LC; Kennedy, WR; Mooring, DL; Novy, DM; Wendelschafer-Crabb, G | 1 |
Glaspy, J; Green, MD; Hackett, J; Holmes, FA; Kubista, E; Neumann, T | 1 |
Baba, S; Egawa, S; Fujita, T; Kuruma, H; Shitara, T; Yokoyama, E | 1 |
Arun, B; Booser, D; Bruera, E; Cleeland, CS; Fritsche, HA; Hortobagyi, GN; Ibrahim, N; Lara, J; Martinez, MM; Mendoza, TR; Pusztai, L; Reuben, JM; Rivera, E; Royce, M; Syed, A; Valero, V; Willey, JS | 1 |
Chen, X; Dina, OA; Levine, JD; McCarter, GC; Parada, CA; Yeh, J | 1 |
Crager, SE; Mogil, JS; Smith, SB | 1 |
Burton, A; Cata, JP; Cordella, JV; Dougherty, PM; Weng, HR | 1 |
Cella, D; McQuellon, RP; Moore, DH; Thaler, HT | 1 |
Bennett, GJ; Flatters, SJ; Xiao, WH | 1 |
Calcutt, NA; Esch, FS; Herbetsson, K; Jolivalt, CG; Ramos, KM | 1 |
Bennett, GJ; Flatters, SJL | 1 |
Hald, A; Inoue, M; Matsumoto, M; Ueda, H; Xie, W | 1 |
Ghilardi, JR; Jimenez-Andrade, JM; Kuskowski, MA; Mantyh, PW; Mejia, NA; Peters, CM | 1 |
Cohen, MH; Gootenberg, J; Keegan, P; Pazdur, R | 1 |
Bennett, GJ; Flatters, SJ; Jin, HW; Mulhern, HL; Xiao, WH | 1 |
Aono, Y; Arai, T; Hidaka, T; Ieki, M; Kuraishi, Y; Nagira, K; Nakamura, T; Saito, S; Shima, T | 1 |
Gudi, R; Krishnamurthy, M; Pachter, BR | 1 |
Aaron, AD | 1 |
Gheka, A; Martoni, A; Pannuti, F; Zamagni, C | 1 |
Nishiwaki, Y; Saijo, N; Sasaki, Y; Tamura, T | 1 |
Boesgaard, M; Dombernowsky, P; Gehl, J; Jensen, BV; Paaske, T | 1 |
Amadori, D; Frassineti, GL; Gentile, A; Milandri, C; Ravaioli, A; Salzano, E; Tienghi, A; Zoli, W | 1 |
Bauknecht, T; Costa, S; du Bois, A; Jackisch, C; Lück, HJ; Meier, W; Möbus, V; Nitz, U; Olbricht, S; Richter, B; Schröder, W; Warm, M | 1 |
Boucher, J; Corey, B; Savarese, D | 1 |
Belinson, J; Kennedy, A; Kulp, B; Markman, M; Peterson, G; Webster, K | 1 |
Bagiella, E; Balog, J; Benson, M; Fine, R; Heitjan, D; Judge, T; Macarthur, RB; O'Connor, J; Olsson, CA; Petrylak, DP; Pfaff, C; Sawczuk, I; Shelton, G; Zuech, N | 1 |
MacDonald, N | 1 |
Bernard, S; van Deventer, H | 1 |
Authier, N; Coudore, F; Eschalier, A; Fialip, J; Gillet, JP | 1 |
Hoshiai, H; Noda, K; Yamamoto, K | 1 |
Godley, PA; Herndon, JE; Kornblith, AB; Savarese, D; Vogelzang, NJ; Zuckerman, E | 1 |
Hiramatsu, H; Kikuchi, Y; Kita, T; Seto, H | 1 |
Beer, TM; Henner, WD; Lowe, BA; Pierce, WC | 1 |
Hasegawa, K; Hiramatsu, Y; Hongo, A; Kodama, J; Kudo, T; Kuramoto, H; Masuyama, H; Mizutani, Y; Nagao, S; Okuda, H; Yoshinouchi, M | 1 |
Beer, TM; Bubalo, JS | 1 |
Buzdar, AU; Forman, AD; Frye, DK; Holmes, FA; Hortobagyi, GN; Newton, LK; Raber, MN; Theriault, RL; Walters, RS | 1 |
Armstrong, DK; Donehower, RC; Ettinger, DS; Grumbine, FC; McGuire, WP; Rosenshein, NB; Rowinsky, EK | 1 |
Adhikari, A; Gul, F; Kaleem, WA; Khan, A; Khan, I; Khan, IA; Khan, N; Nisar, M; Qayum, M; Shah, MR; Zia-Ul-Haq, M | 1 |
Gilani, AH; Khan, I; Nisar, M; Perveen, H; Simjee, SU | 1 |
2 review(s) available for paclitaxel and Ache
Article | Year |
---|---|
Recent advances in understanding chemotherapy-induced peripheral neuropathy.
Topics: Antineoplastic Agents; Humans; Neoplasms; Paclitaxel; Pain; Peripheral Nervous System Diseases; Quality of Life | 2020 |
Effects of docetaxel on pain due to metastatic androgen-independent prostate cancer.
Topics: Aged; Androgens; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Docetaxel; Humans; Male; Paclitaxel; Pain; Prostatic Neoplasms; Taxoids | 2002 |
15 trial(s) available for paclitaxel and Ache
Article | Year |
---|---|
A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors.
Topics: Albumins; Fibromatosis, Aggressive; Humans; Paclitaxel; Pain | 2022 |
Pharmacological Modulation of the Mitochondrial Electron Transport Chain in Paclitaxel-Induced Painful Peripheral Neuropathy.
Topics: Animals; Antimycin A; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Electron Transport; Electron Transport Chain Complex Proteins; Enzyme Inhibitors; Hyperalgesia; Male; Motor Activity; Paclitaxel; Pain; Pain Measurement; Peripheral Nervous System Diseases; Psychomotor Disorders; Rats; Rats, Sprague-Dawley; Rotenone; Single-Blind Method; Time Factors | 2015 |
Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Deoxycytidine; Drug-Related Side Effects and Adverse Reactions; Female; Gemcitabine; Humans; Middle Aged; Paclitaxel; Pain; Pain Measurement; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Quality of Life; Treatment Outcome | 2016 |
Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cisplatin; Disease-Free Survival; Drug Combinations; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Oxonic Acid; Paclitaxel; Pain; Salvage Therapy; Severity of Illness Index; Stomach Neoplasms; Survival Rate; Tegafur; Treatment Outcome | 2009 |
Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in cutaneous and mucosal metastatic melanoma patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Diarrhea; Exanthema; Fatigue; Female; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Male; Melanoma; Middle Aged; Neutropenia; Paclitaxel; Pain; Skin Neoplasms; Survival Rate; Tumor Burden | 2009 |
Weekly paclitaxel plus estramustine combination therapy in hormone-refractory prostate cancer: a pilot study.
Topics: Adenocarcinoma; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Drug Administration Schedule; Estramustine; Humans; Infusions, Intravenous; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Pain; Pilot Projects; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Treatment Outcome | 2003 |
Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Blood; Breast Neoplasms; Cyclophosphamide; Cytokines; Data Interpretation, Statistical; Doxorubicin; Fatigue; Female; Fluorouracil; Humans; Interleukin-1; Interleukin-10; Interleukin-12; Interleukin-6; Interleukin-8; Middle Aged; Nausea; Paclitaxel; Pain; Patient Selection; Quality of Life; Tumor Necrosis Factor-alpha | 2004 |
Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Middle Aged; Paclitaxel; Pain; Quality of Life; Treatment Outcome; Uterine Cervical Neoplasms | 2006 |
Phase I study of paclitaxel by three-hour infusion: hypotension just after infusion is one of the major dose-limiting toxicities.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents, Phytogenic; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity; Female; Histamine Antagonists; Humans; Hypotension; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Paclitaxel; Pain; Peripheral Nervous System Diseases; Premedication | 1995 |
A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Arthralgia; Breast Neoplasms; Chemotherapy, Adjuvant; Dose-Response Relationship, Drug; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Heart; Humans; Infusions, Intravenous; Injections, Intravenous; Middle Aged; Muscular Diseases; Neutropenia; Paclitaxel; Pain; Peripheral Nervous System Diseases; Remission Induction; Stroke Volume; Ventricular Function, Left | 1996 |
Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase III trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Arthralgia; Carboplatin; Dose-Response Relationship, Drug; Female; Germany; Humans; Infusions, Intravenous; Middle Aged; Neoplasm, Residual; Neutropenia; Ovarian Neoplasms; Paclitaxel; Pain; Patient Selection; Peripheral Nervous System Diseases; Prospective Studies; Quality of Life; Remission Induction; Retrospective Studies; Single-Blind Method; Survival Rate; Thrombocytopenia; Vomiting | 1997 |
Phase I trial of docetaxel with estramustine in androgen-independent prostate cancer.
Topics: Aged; Aged, 80 and over; Androgens; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Response Relationship, Drug; Estramustine; Gastrointestinal Diseases; Hematologic Diseases; Humans; Male; Middle Aged; Paclitaxel; Pain; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Analysis; Taxoids | 1999 |
The impact of docetaxel, estramustine, and low dose hydrocortisone on the quality of life of men with hormone refractory prostate cancer and their partners: a feasibility study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Docetaxel; Drug Resistance, Neoplasm; Emotions; Estramustine; Feasibility Studies; Female; Health Status; Humans; Hydrocortisone; Infusions, Intravenous; Male; Mental Health; Middle Aged; Paclitaxel; Pain; Prostatic Neoplasms; Quality of Life; Sexual Behavior; Spouses; Taxoids | 2001 |
Phase II study of weekly docetaxel in symptomatic androgen-independent prostate cancer.
Topics: Aged; Aged, 80 and over; Analgesics; Antineoplastic Agents, Phytogenic; Disease Progression; Docetaxel; Drug Administration Schedule; Humans; Infusions, Intravenous; Male; Middle Aged; Paclitaxel; Pain; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids | 2001 |
Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer.
Topics: Adult; Aged; Agranulocytosis; Alkaloids; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Doxorubicin; Drug Evaluation; Female; Heart Diseases; Humans; Methotrexate; Middle Aged; Muscular Diseases; Paclitaxel; Pain; Peripheral Nervous System Diseases; Remission Induction; Soft Tissue Neoplasms; Thrombocytopenia | 1991 |
71 other study(ies) available for paclitaxel and Ache
Article | Year |
---|---|
Dual PI3Kδ/γ Inhibitor Duvelisib Prevents Development of Neuropathic Pain in Model of Paclitaxel-Induced Peripheral Neuropathy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Female; Hyperalgesia; Isoquinolines; Male; Mice; Neuralgia; Paclitaxel; Pain; Peripheral Nervous System Diseases; Phosphatidylinositol 3-Kinases; Purines; Rats | 2022 |
Participation of transient receptor potential vanilloid 1 in the analgesic effect of duloxetine for paclitaxel induced peripheral neuropathic pain.
Topics: Analgesics; Animals; Antineoplastic Agents; Calcitonin Gene-Related Peptide; Duloxetine Hydrochloride; Ganglia, Spinal; Hyperalgesia; Neuralgia; Paclitaxel; Pain; Peripheral Nervous System Diseases; Rats; Spinal Cord Dorsal Horn; Substance P; TRPV Cation Channels; Tumor Necrosis Factor-alpha | 2022 |
Pancreatic intra-arterial infusion chemotherapy for the treatment of patients with advanced pancreatic carcinoma: A pilot study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Infusions, Intra-Arterial; Male; Paclitaxel; Pain; Pancreatic Neoplasms; Pilot Projects; Quality of Life; Treatment Outcome | 2022 |
Kinin B
Topics: Animals; Antineoplastic Agents; Aromatase Inhibitors; Bradykinin; Cancer Pain; Hyperalgesia; Mice; Neoplasms; Paclitaxel; Pain; Receptor, Bradykinin B1; Receptor, Bradykinin B2 | 2023 |
Protease-Activated Receptor 2 (PAR2) Expressed in Sensory Neurons Contributes to Signs of Pain and Neuropathy in Paclitaxel Treated Mice.
Topics: Animals; Female; Ganglia, Spinal; Gliosis; Hyperalgesia; Male; Mice; Mice, Knockout; Paclitaxel; Pain; Peripheral Nervous System Diseases; Receptor, PAR-2; Sensory Receptor Cells | 2023 |
A simple method of quantifying chemotherapy-induced peripheral neuropathy using PainVision PS-2100
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Fallopian Tube Neoplasms; Female; Humans; Incidence; Japan; Middle Aged; Ovarian Neoplasms; Paclitaxel; Pain; Peripheral Nervous System Diseases; Peritoneal Neoplasms; Pilot Projects; Risk Assessment; Risk Factors; Skin; Young Adult | 2020 |
Efficacy of the World Health Organization analgesic ladder in the paclitaxel-induced pain syndrome in rats.
Topics: Acetaminophen; Analgesics; Animals; Codeine; Drug Combinations; Male; Morphine; Paclitaxel; Pain; Rats; Rats, Wistar; World Health Organization | 2020 |
Dysregulation of EAAT2 and VGLUT2 Spinal Glutamate Transports via Histone Deacetylase 2 (HDAC2) Contributes to Paclitaxel-induced Painful Neuropathy.
Topics: Animals; Excitatory Amino Acid Transporter 2; Glutamic Acid; Histone Deacetylase 2; Male; Paclitaxel; Pain; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Vesicular Glutamate Transport Protein 2 | 2020 |
Effects of chemotherapy on operant responding for palatable food in male and female mice.
Topics: Animal Feed; Animals; Antineoplastic Agents; Behavior, Animal; Conditioning, Operant; Depression; Female; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Oxaliplatin; Paclitaxel; Pain; Sex Factors | 2021 |
Paclitaxel-induced painful neuropathy is associated with changes in mitochondrial bioenergetics, glycolysis, and an energy deficit in dorsal root ganglia neurons.
Topics: Animals; Antineoplastic Agents, Phytogenic; Energy Metabolism; Ganglia, Spinal; Glycolysis; Male; Mitochondria; Neurons; Paclitaxel; Pain; Peripheral Nervous System Diseases; Rats, Sprague-Dawley | 2017 |
Lack of paclitaxel effects on intracranial self-stimulation in male and female rats: comparison to mechanical sensitivity.
Topics: Analgesics, Opioid; Animals; Conditioning, Operant; Electric Stimulation; Female; Male; Medial Forebrain Bundle; Neuralgia; Paclitaxel; Pain; Pain Management; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Stimulation | 2018 |
Machine Learning Methods to Extract Documentation of Breast Cancer Symptoms From Electronic Health Records.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cohort Studies; Electronic Health Records; Fatigue; Female; Humans; Machine Learning; Male; Middle Aged; Nausea; Paclitaxel; Pain | 2018 |
Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer.
Topics: Adenocarcinoma; Aged; Albumin-Bound Paclitaxel; Albumins; Antineoplastic Agents; CA-19-9 Antigen; Disease-Free Survival; Female; Humans; Italy; Kaplan-Meier Estimate; Linear Models; Male; Middle Aged; Paclitaxel; Pain; Pancreatic Neoplasms; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2018 |
Phenotypic Characterization of Paclitaxel-Induced Peripheral Neuropathy in Cancer Survivors.
Topics: Antineoplastic Agents, Phytogenic; Cancer Survivors; Cost of Illness; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Paclitaxel; Pain; Peripheral Nervous System Diseases; Postural Balance; Quality of Life; Socioeconomic Factors; Stress, Psychological | 2018 |
Beneficial effects of Gelsemium-based treatment against paclitaxel-induced painful symptoms.
Topics: Analysis of Variance; Animals; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Dose-Response Relationship, Drug; Gelsemium; Hyperalgesia; Male; Paclitaxel; Pain; Pain Measurement; Pain Threshold; Peripheral Nervous System Diseases; Plant Extracts; Rats; Rats, Sprague-Dawley; Sciatic Nerve | 2018 |
A light-gated potassium channel for sustained neuronal inhibition.
Topics: Action Potentials; Animals; Female; Hyperalgesia; Light; Male; Mice, Inbred C57BL; Neurons; Optogenetics; Paclitaxel; Pain; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Recombinant Fusion Proteins; Zebrafish | 2018 |
Interleukin-1beta released by microglia initiates the enhanced glutamatergic activity in the spinal dorsal horn during paclitaxel-associated acute pain syndrome.
Topics: Animals; Antineoplastic Agents; Calcium; Excitatory Postsynaptic Potentials; Glutamic Acid; Interleukin-1beta; Male; Mice; Mice, Knockout; Microglia; Miniature Postsynaptic Potentials; Paclitaxel; Pain; Pain Measurement; Rats; Spinal Cord Dorsal Horn | 2019 |
Cisplatin educates CD8+ T cells to prevent and resolve chemotherapy-induced peripheral neuropathy in mice.
Topics: Animals; Antineoplastic Agents; CD8-Positive T-Lymphocytes; Cisplatin; Disease Models, Animal; Female; Hyperalgesia; Male; Mice, Transgenic; Paclitaxel; Pain; Peripheral Nervous System Diseases | 2019 |
Outcomes evaluation of a weekly nurse practitioner-managed symptom management clinic for patients with head and neck cancer treated with chemoradiotherapy.
Topics: Academic Medical Centers; Aged; Antineoplastic Combined Chemotherapy Protocols; Cachexia; Cancer Care Facilities; Carboplatin; Chemoradiotherapy; Dehydration; Gastrointestinal Diseases; Head and Neck Neoplasms; Hospitalization; Humans; Middle Aged; Mucositis; Nurse Practitioners; Outpatient Clinics, Hospital; Paclitaxel; Pain; Patient Compliance; Program Evaluation; Retrospective Studies; Treatment Outcome | 2013 |
Effect of ω-conotoxin MVIIA and Phα1β on paclitaxel-induced acute and chronic pain.
Topics: Acute Disease; Analgesics; Animals; Behavior, Animal; Chronic Disease; Male; omega-Conotoxins; Paclitaxel; Pain; Rats; Rats, Wistar; Spider Venoms | 2013 |
Neurosteroid 3α-androstanediol efficiently counteracts paclitaxel-induced peripheral neuropathy and painful symptoms.
Topics: Action Potentials; Androstane-3,17-diol; Animals; Antineoplastic Agents, Phytogenic; Hyperalgesia; Male; Nerve Fibers; Neural Conduction; Neuralgia; Neuroprotective Agents; Paclitaxel; Pain; Pain Measurement; Peripheral Nerves; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley | 2013 |
[Cancer, pain and treatment].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Female; Humans; Neoplasms; Paclitaxel; Pain; Pain Management; Paraneoplastic Polyneuropathy; Peripheral Nervous System Diseases | 2014 |
CX3CL1-mediated macrophage activation contributed to paclitaxel-induced DRG neuronal apoptosis and painful peripheral neuropathy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Chemokine CX3CL1; Ganglia, Spinal; Macrophage Activation; Macrophages; Male; Neurons; Paclitaxel; Pain; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Up-Regulation | 2014 |
Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase III as Topic; Deglutition Disorders; Deoxycytidine; Gemcitabine; Humans; Interpersonal Relations; Lung Neoplasms; Multicenter Studies as Topic; Nausea; Paclitaxel; Pain; Palliative Care; Prognosis; Proportional Hazards Models; Quality of Life; Randomized Controlled Trials as Topic; Risk; Severity of Illness Index; Surveys and Questionnaires; Survival Analysis | 2014 |
Recovery sleep does not mitigate the effects of prior sleep loss on paclitaxel-induced mechanical hypersensitivity in Sprague-Dawley rats.
Topics: Animals; Female; Male; Paclitaxel; Pain; Physical Stimulation; Rats; Rats, Sprague-Dawley; Sex Factors; Wakefulness | 2015 |
Nociceptor beta II, delta, and epsilon isoforms of PKC differentially mediate paclitaxel-induced spontaneous and evoked pain.
Topics: Animals; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Activation; Ganglia, Spinal; Male; Mice; Mice, Inbred ICR; Nociceptors; Paclitaxel; Pain; Protein Isoforms; Protein Kinase C beta; Protein Kinase C-delta; Protein Kinase C-epsilon; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley | 2015 |
[A case of stage IV breast cancer with improved cancer pain using bevacizumab and paclitaxel].
Topics: Aged; Analgesics, Opioid; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Female; Humans; Neoplasm Staging; Oxycodone; Paclitaxel; Pain | 2015 |
Urinary N telopeptide levels in predicting the anti-nociceptive responses of zoledronic acid and paclitaxel in a rat model of bone metastases.
Topics: Acid Sensing Ion Channels; Analgesics; Animals; Biomarkers; Bone Neoplasms; Cell Line, Tumor; Collagen Type I; Diphosphonates; Drug Evaluation, Preclinical; Female; Ganglia, Spinal; Hyperalgesia; Imidazoles; Neoplasm Transplantation; Osteoclasts; Paclitaxel; Pain; Peptides; Proto-Oncogene Proteins c-fos; Rats, Wistar; Spinal Cord; Zoledronic Acid | 2015 |
Identifying the Role of Novel Protein Kinase C Isoforms in Mediating Paclitaxel-Induced Peripheral Neuropathy.
Topics: Animals; Male; Nociceptors; Paclitaxel; Pain; Protein Kinase C beta; Protein Kinase C-delta; Protein Kinase C-epsilon | 2015 |
CX3CR1-Mediated Akt1 Activation Contributes to the Paclitaxel-Induced Painful Peripheral Neuropathy in Rats.
Topics: Animals; CX3C Chemokine Receptor 1; Male; Paclitaxel; Pain; Pain Measurement; Peripheral Nervous System Diseases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, Chemokine | 2016 |
Oxidative stress in the development, maintenance and resolution of paclitaxel-induced painful neuropathy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Astrocytes; Cells, Cultured; Disease Models, Animal; Disease Progression; Ganglia, Spinal; Hyperalgesia; Lumbar Vertebrae; Male; Microglia; Neurons; Oxidative Stress; Paclitaxel; Pain; Peripheral Nervous System Diseases; Rats, Sprague-Dawley; Reactive Oxygen Species; Spinal Cord | 2016 |
Involvement of high mobility group box 1 in the development and maintenance of chemotherapy-induced peripheral neuropathy in rats.
Topics: Animals; Antibodies, Neutralizing; Antineoplastic Agents; Disease Models, Animal; Ganglia, Spinal; HMGB1 Protein; Hyperalgesia; Male; Paclitaxel; Pain; Peripheral Nervous System Diseases; Rats; Rats, Wistar; Receptor for Advanced Glycation End Products; Recombinant Proteins; Sciatic Nerve; Thrombomodulin; Toll-Like Receptor 4; Vincristine | 2016 |
Paclitaxel-induced sickle cell crisis.
Topics: Anemia, Sickle Cell; Antineoplastic Agents, Phytogenic; Black or African American; Breast Neoplasms; Female; Humans; Middle Aged; Paclitaxel; Pain | 2008 |
Effects of the prostaglandin E1 analog limaprost on mechanical allodynia caused by chemotherapeutic agents in mice.
Topics: alpha-Cyclodextrins; Alprostadil; Animals; Antineoplastic Agents; Drug Administration Schedule; Male; Mice; Mice, Inbred C57BL; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Pain; Pain Measurement; Vincristine | 2009 |
Mechanical allodynia induced by paclitaxel, oxaliplatin and vincristine: different effectiveness of gabapentin and different expression of voltage-dependent calcium channel alpha(2)delta-1 subunit.
Topics: Administration, Oral; Amines; Analgesics, Non-Narcotic; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Behavior, Animal; Calcium Channels; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Ganglia, Spinal; Gene Expression; Injections, Spinal; Male; Mice; Mice, Inbred C57BL; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Pain; Peripheral Nervous System Diseases; Reverse Transcriptase Polymerase Chain Reaction; Spinal Cord; Vincristine | 2009 |
Phenyl N-tert-butylnitrone, a free radical scavenger, reduces mechanical allodynia in chemotherapy-induced neuropathic pain in rats.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Behavior, Animal; Body Weight; Cyclic N-Oxides; Dose-Response Relationship, Drug; Free Radical Scavengers; Hypnotics and Sedatives; Male; Neuroprotective Agents; Paclitaxel; Pain; Pain Measurement; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley | 2010 |
Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain.
Topics: Animals; Behavior, Animal; Biotransformation; Cannabinoids; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Hydrazines; Indoles; Male; Mice; Mice, Knockout; Paclitaxel; Pain; Pain Measurement; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Spinal Nerves | 2010 |
Role of satellite cell-derived L-serine in the dorsal root ganglion in paclitaxel-induced painful peripheral neuropathy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cold Temperature; Ganglia, Spinal; Hyperalgesia; Male; Neural Conduction; Paclitaxel; Pain; Peripheral Nervous System Diseases; Phosphoglycerate Dehydrogenase; Rats; Rats, Sprague-Dawley; Satellite Cells, Perineuronal; Serine; Stereoisomerism; Tail; Touch | 2011 |
Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1.
Topics: Acute Disease; Antineoplastic Agents, Phytogenic; Area Under Curve; Chi-Square Distribution; Female; Humans; Middle Aged; Paclitaxel; Pain; Pain Measurement; Peripheral Nervous System Diseases; Prospective Studies; Statistics, Nonparametric; Surveys and Questionnaires; Syndrome | 2011 |
Abnormal muscle afferent function in a model of Taxol chemotherapy-induced painful neuropathy.
Topics: Action Potentials; Afferent Pathways; Animals; Antineoplastic Agents; Disease Models, Animal; Male; Muscle, Skeletal; Paclitaxel; Pain; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley | 2011 |
Antinociceptive efficacy of verticinone in murine models of inflammatory pain and paclitaxel induced neuropathic pain.
Topics: Analgesics; Animals; Cevanes; Disease Models, Animal; Inflammation; Mice; Mice, Inbred ICR; Paclitaxel; Pain; Peripheral Nervous System Diseases | 2011 |
Comparison of peripheral neuropathy induced by standard and nanoparticle albumin-bound paclitaxel in rats.
Topics: Albumins; Animals; Antineoplastic Agents, Phytogenic; Cold Temperature; Dose-Response Relationship, Drug; Hand Strength; Hyperalgesia; Male; Motor Skills; Nanoparticles; Paclitaxel; Pain; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley | 2011 |
Use of low-dose combined therapy with gemcitabine and paclitaxel for advanced urothelial cancer patients with resistance to cisplatin-containing therapy: a retrospective analysis.
Topics: Aged; Analgesics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Drug Resistance, Neoplasm; Feasibility Studies; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Pain; Pain Measurement; Retrospective Studies; Salvage Therapy; Treatment Outcome; Urologic Neoplasms; Urothelium | 2012 |
Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristine.
Topics: Aged; Antineoplastic Agents, Phytogenic; Biopsy; Female; Humans; Male; Mechanoreceptors; Middle Aged; Motor Skills; Nerve Fibers; Neurotoxicity Syndromes; Paclitaxel; Pain; Pain Measurement; Peripheral Nervous System Diseases; Physical Stimulation; Pilot Projects; Sensory Thresholds; Skin; Thermosensing; Touch; Vincristine | 2013 |
Bone pain associated with once-per-cycle pegfilgrastim is similar to daily filgrastim in patients with breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Breast Neoplasms; Docetaxel; Double-Blind Method; Doxorubicin; Drug Administration Schedule; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Injections, Subcutaneous; Middle Aged; Multicenter Studies as Topic; Narcotics; Neoplasm Metastasis; Paclitaxel; Pain; Pain Measurement; Polyethylene Glycols; Randomized Controlled Trials as Topic; Recombinant Proteins; Retrospective Studies; Taxoids | 2003 |
Integrin signaling in inflammatory and neuropathic pain in the rat.
Topics: Animals; Animals, Genetically Modified; Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Blotting, Western; Carrageenan; Dinoprostone; Dose-Response Relationship, Drug; Drug Interactions; Epinephrine; Extracellular Matrix Proteins; Fibronectins; Inflammation; Integrins; Male; Nerve Fibers, Unmyelinated; Oligodeoxyribonucleotides, Antisense; Paclitaxel; Pain; Pain Measurement; Pain Threshold; Peptides; Protein Kinase C; Protein Kinase C-epsilon; Protein Subunits; Rats; Rats, Sprague-Dawley; Signal Transduction; Time Factors | 2004 |
Paclitaxel-induced neuropathic hypersensitivity in mice: responses in 10 inbred mouse strains.
Topics: Analysis of Variance; Animals; Antineoplastic Agents, Phytogenic; Cold Temperature; Disease Models, Animal; Female; Hot Temperature; Hyperalgesia; Male; Mice; Mice, Inbred Strains; Paclitaxel; Pain; Peripheral Nervous System Diseases; Physical Stimulation; Species Specificity | 2004 |
Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Female; Humans; Male; Middle Aged; Neoplasms; Nerve Fibers, Myelinated; Nociceptors; Paclitaxel; Pain; Pain Threshold; Psychomotor Performance; Sensation Disorders; Sensory Thresholds; Skin; Time Factors | 2004 |
Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy.
Topics: Acetylcarnitine; Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Male; Paclitaxel; Pain; Pain Measurement; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley | 2006 |
Therapeutic efficacy of prosaposin-derived peptide on different models of allodynia.
Topics: Analgesics, Non-Narcotic; Analysis of Variance; Animals; Diabetes Complications; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Nerve Growth Factors; Paclitaxel; Pain; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Sciatica; Skin; Time Factors | 2006 |
Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction.
Topics: Animals; Antineoplastic Agents, Phytogenic; Axons; Behavior, Animal; Male; Microscopy, Electron; Microtubules; Mitochondria; Nerve Fibers, Unmyelinated; Neurons, Afferent; Paclitaxel; Pain; Peripheral Nerves; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley | 2006 |
Inhibition of paclitaxel-induced A-fiber hypersensitization by gabapentin.
Topics: Amines; Animals; Antineoplastic Agents, Phytogenic; Behavior, Animal; Blotting, Western; Calcium Channels; Cyclohexanecarboxylic Acids; Electric Stimulation; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Ganglia, Spinal; Immunohistochemistry; Ion Channel Gating; Male; Mice; Myelin Sheath; Nerve Fibers, Myelinated; Paclitaxel; Pain; Pain Measurement; Peripheral Nervous System Diseases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2006 |
Sensory neurons and their supporting cells located in the trigeminal, thoracic and lumbar ganglia differentially express markers of injury following intravenous administration of paclitaxel in the rat.
Topics: Activating Transcription Factor 3; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Agents, Phytogenic; Biomarkers; Ganglia, Spinal; Glial Fibrillary Acidic Protein; Injections, Intravenous; Lumbosacral Region; Male; Neurons, Afferent; Paclitaxel; Pain; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Thorax; Trigeminal Ganglion | 2006 |
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Non-Small-Cell Lung; Drug Approval; Headache; Humans; Lung Neoplasms; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Neoplasm Staging; Paclitaxel; Pain; Randomized Controlled Trials as Topic; Treatment Outcome; United States; United States Food and Drug Administration; Vomiting | 2007 |
Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells.
Topics: Acetylcarnitine; Animals; Axons; Behavior, Animal; Disease Models, Animal; Drug Interactions; Langerhans Cells; Male; Microscopy, Electron, Transmission; Mitochondria; Paclitaxel; Pain; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Sensory Receptor Cells; Skin | 2008 |
Herbal medicine Shakuyaku-kanzo-to reduces paclitaxel-induced painful peripheral neuropathy in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Behavior, Animal; Drug Combinations; Drugs, Chinese Herbal; Glycyrrhiza; Hyperalgesia; Male; Mice; Paclitaxel; Paeonia; Pain; Pain Measurement; Peripheral Nervous System Diseases; Phenylpropionates; Physical Stimulation | 2009 |
Astemizole in the treatment of granulocyte colony-stimulating factor-induced bone pain.
Topics: Astemizole; Bone and Bones; Breast Neoplasms; Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Paclitaxel; Pain | 1995 |
The management of cancer metastatic to bone.
Topics: Acetabulum; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Female; Femur; Fractures, Spontaneous; Hip Prosthesis; Humans; Middle Aged; Paclitaxel; Pain; Tomography, X-Ray Computed | 1994 |
Antihistamines in the treatment of taxol-induced paroxystic pain syndrome.
Topics: Female; Histamine H1 Antagonists; Humans; Paclitaxel; Pain; Syndrome | 1993 |
Doxorubicin and paclitaxel, a highly active combination in the treatment of metastatic breast cancer.
Topics: Adult; Aged; Alopecia; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Progression; Doxorubicin; Female; Heart; Heart Failure; Humans; Infusions, Intravenous; Middle Aged; Muscular Diseases; Nausea; Neoplasm Metastasis; Neutropenia; Paclitaxel; Pain; Paresthesia; Remission Induction; Stroke Volume; Ventricular Function, Left; Vomiting | 1996 |
Glutamine treatment of paclitaxel-induced myalgias and arthralgias.
Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Arthralgia; Female; Glutamine; Humans; Male; Middle Aged; Muscles; Neoplasms; Paclitaxel; Pain | 1998 |
Use of low-dose oral prednisone to prevent paclitaxel-induced arthralgias and myalgias.
Topics: Administration, Oral; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Arthralgia; Female; Genital Neoplasms, Female; Humans; Muscular Diseases; Paclitaxel; Pain; Prednisone | 1999 |
Best supportive care.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Attitude of Health Personnel; Carcinoma, Non-Small-Cell Lung; Critical Illness; Humans; Lung Neoplasms; Neoplasms; Paclitaxel; Pain; Pain Management; Palliative Care; Terminology as Topic | 1998 |
Use of gabapentin to treat taxane-induced myalgias.
Topics: Acetates; Amines; Analgesics; Antineoplastic Agents, Phytogenic; Cyclohexanecarboxylic Acids; Docetaxel; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Middle Aged; Muscular Diseases; Paclitaxel; Pain; Taxoids | 1999 |
Description of a short-term Taxol-induced nociceptive neuropathy in rats.
Topics: Animals; Hair; Hand Strength; Hot Temperature; Hyperalgesia; Male; Motor Activity; Neural Conduction; Neuralgia; Nociceptors; Paclitaxel; Pain; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Somatosensory Disorders | 2000 |
Effects of shakuyaku-kanzo-to on muscle pain from combination chemotherapy with paclitaxel and carboplatin.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Combinations; Drugs, Chinese Herbal; Female; Glycyrrhiza; Humans; Muscular Diseases; Ovarian Neoplasms; Paclitaxel; Paeonia; Pain | 2001 |
A rare case of advanced ovarian carcinoma who developed difficulty walking 25 days after treatment with weekly paclitaxel.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma; Female; Humans; Leg; Middle Aged; Ovarian Neoplasms; Paclitaxel; Pain; Peripheral Nervous System Diseases; Proprioception | 2001 |
[The effect of L-Glutamine and Shakuyaku-Kanzo-to for paclitaxel-induced myalgia/arthralgia].
Topics: Antineoplastic Agents, Phytogenic; Arthralgia; Drug Administration Schedule; Drug Combinations; Drugs, Chinese Herbal; Female; Glutamine; Glycyrrhiza; Humans; Muscle, Skeletal; Neoplasms; Paclitaxel; Paeonia; Pain; Quality of Life | 2002 |
Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms.
Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Arrhythmias, Cardiac; Cisplatin; Drug Evaluation; Epilepsy, Tonic-Clonic; Female; Hematologic Diseases; Humans; Joint Diseases; Muscular Diseases; Ovarian Neoplasms; Paclitaxel; Pain; Peripheral Nervous System Diseases | 1989 |
Analgesic and antiinflammatory activities of taxoids from Taxus wallichiana Zucc.
Topics: Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents; Carrageenan; Drug Evaluation, Preclinical; Edema; Female; Inflammation; Lipoxygenase Inhibitors; Male; Pain; Phytotherapy; Plant Bark; Rats; Rats, Wistar; Taxoids; Taxus | 2012 |
Anticonvulsant, analgesic and antipyretic activities of Taxus wallichiana Zucc.
Topics: Analgesics; Analgesics, Non-Narcotic; Animals; Anticonvulsants; Female; Fever; Male; Mice; Pain; Phytotherapy; Plant Extracts; Plant Leaves; Rats; Rats, Wistar; Seizures; Taxus | 2008 |